66 Optimising post-MI lipid treatment: experience from a UK district general hospital

Introduction Intensive control of LDL cholesterol (LDL-C) following myocardial infarction (MI) are recommended by European Society of Cardiology (ESC) guidelines, to improve clinical outcomes. In this retrospective analysis, we report experiences and trends of lipid management by clinical cardiologists from a UK District General Hospital. Methods Post-MI patients on high-intensity statin not meeting Low Density Lipoprotein-Cholesterol (LDL-C) targets of Results Fifty six percent of patients in the lipid clinic had ST-elevation MI. Baseline CV risk factors included hypertension (41%), diabetes (18%), family Hx 291(52.8%), smoking (60%), prior CAD/ MI (9%). LDL during index admission (mean+/-standard deviation SD) was 3.17 +/-1.28 mmol/l; total cholesterol was 5.05+/-1.41 mmol/l. 62% of patients had LDL> 1.4 mmol/L. At first follow up (i.e. post-MI clinic), mean LDL-C was 2.12+/-0.69 mmol/l and cholesterol was 4.06 +/-0.93 mmol/l. Only 5% had met the ESC LDL target Conclusion In this analysis, we demonstrate the feasibility and importance of follow-up clinics for optimising lipid lowering therapy to intensive targets in post-MI patients by clinical cardiologists at DGH level. Conflict of Interest None